COMPUS Communiqué — Vol. 4, No. 3

In This Issue

• Diabetes Management Topic Area
• Proton Pump Inhibitor Topic Area
• Employment Opportunities
• Feedback

Diabetes Management Topic Area

The Canadian Agency for Drugs and Technologies in Health (CADTH), through its Canadian Optimal Medication Prescribing and Utilization Service (COMPUS), is producing a series of optimal therapy reports on the insulin analogues component of our diabetes management topic area.

Insulin Analogues: Meta-analyses

COMPUS has reviewed and updated the Optimal Therapy Report on Long-Acting Insulin Analogues for the Treatment of Diabetes Mellitus: Meta-analyses of Clinical Outcomes originally posted on the CADTH web site on February 21, 2008.

The final report and summary of revisions are now available on the CADTH web site.

Proton Pump Inhibitor Topic Area

Uptake of COMPUS Information on Proton Pump Inhibitors

The variety of ready-to-use products and tools developed by COMPUS to assist decision makers and educators in conveying COMPUS key messages on proton pump inhibitors (PPIs) is being widely used across Canada. Examples of how COMPUS is supporting decision makers in moving toward optimal drug therapy have been posted to the CADTH web site. This information will be updated on a quarterly basis. If you have any questions, please contact COMPUS at compusinfo@cadth.ca.

Employment Opportunities

Research Assistant — COMPUS (one-year term)

CADTH has many exciting job openings. If you’re interested in joining our growing team of professionals, visit Careers/Job Listings.

Feedback

We welcome your feedback. Tell us what you think of the COMPUS Communiqué.